跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BYFAVO 20 MG POLVO PARA SOLUCION INYECTABLE - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
BYFAVO 20 MG POLVO PARA SOLUCION INYECTABLE
Approved
STANDARD
BYFAVO 20 MG POLVO PARA SOLUCION INYECTABLE
Paion Pharma Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 31, 2023
Approval ID
07fd69392e560a93
Company
Paion Pharma Gmbh
Type
Standard
Approval Details
Approval Id
07fd69392e560a93
Drug Cima Aemps Name
BYFAVO 20 MG POLVO PARA SOLUCION INYECTABLE
Register Number
1201505001
Holder Company Name
Paion Pharma Gmbh
Marketing Company Name
Viatris Pharmaceuticals S.L.U.
Holder Company Detail Path
/organization/paion-pharma-gmbh
Authorization Date
2023-07-31
Dosage Form
POLVO PARA SOLUCIÓN INYECTABLE
Dose
20 MG
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario. Psicótropos
Commercialized
No
Company Name
Paion Pharma Gmbh
Company Detail Path
/organization/paion-pharma-gmbh
Company Information
Pharmaceutical Company Name
Paion Pharma GmbH
Country Name
Germany
City Name
aachen,nordrhein-westfalen,country_de
Address
Heussstr. 25
Active Ingredients
REMIMAZOLAM BESILATO
27,2 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 31, 2023
Approval ID
07fd69392e560a93
Type
Standard
Back to CIMA-AEMPS Approvals
